Genetic Determinants of Plasma Low-Density Lipoprotein Cholesterol Levels: Monogenicity, Polygenicity, and "Missing" Heritability

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2021 Nov 27

PMID 34829957

Authors

Jesus Maria Martin-Campos

Affiliations

Soon will be listed here.

Abstract

Changes in plasma low-density lipoprotein cholesterol (LDL-c) levels relate to a high risk of developing some common and complex diseases. LDL-c, as a quantitative trait, is multifactorial and depends on both genetic and environmental factors. In the pregenomic age, targeted genes were used to detect genetic factors in both hyper- and hypolipidemias, but this approach only explained extreme cases in the population distribution. Subsequently, the genetic basis of the less severe and most common dyslipidemias remained unknown. In the genomic age, performing whole-exome sequencing in families with extreme plasma LDL-c values identified some new candidate genes, but it is unlikely that such genes can explain the majority of inexplicable cases. Genome-wide association studies (GWASs) have identified several single-nucleotide variants (SNVs) associated with plasma LDL-c, introducing the idea of a polygenic origin. Polygenic risk scores (PRSs), including LDL-c-raising alleles, were developed to measure the contribution of the accumulation of small-effect variants to plasma LDL-c. This paper discusses other possibilities for unexplained dyslipidemias associated with LDL-c, such as mosaicism, maternal effect, and induced epigenetic changes. Future studies should consider gene-gene and gene-environment interactions and the development of integrated information about disease-driving networks, including phenotypes, genotypes, transcription, proteins, metabolites, and epigenetics.

References

Vinje T, Wierod L, Leren T, Strom T . Prevalence of cholesteryl ester storage disease among hypercholesterolemic subjects and functional characterization of mutations in the lysosomal acid lipase gene. Mol Genet Metab. 2017; 123(2):169-176. DOI: 10.1016/j.ymgme.2017.11.008. View

Cohain A, Barrington W, Jordan D, Beckmann N, Argmann C, Houten S . An integrative multiomic network model links lipid metabolism to glucose regulation in coronary artery disease. Nat Commun. 2021; 12(1):547. PMC: 7822923. DOI: 10.1038/s41467-020-20750-8. View

Young S, Northey S, McCarthy B . Low plasma cholesterol levels caused by a short deletion in the apolipoprotein B gene. Science. 1988; 241(4865):591-3. DOI: 10.1126/science.3399894. View

Innerarity T, Weisgraber K, Arnold K, Mahley R, Krauss R, Vega G . Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding. Proc Natl Acad Sci U S A. 1987; 84(19):6919-23. PMC: 299196. DOI: 10.1073/pnas.84.19.6919. View

Winkler T, Day F, Croteau-Chonka D, Wood A, Locke A, Magi R . Quality control and conduct of genome-wide association meta-analyses. Nat Protoc. 2014; 9(5):1192-212. PMC: 4083217. DOI: 10.1038/nprot.2014.071. View

Susan-Resiga D, Girard E, Essalmani R, Roubtsova A, Marcinkiewicz J, Derbali R . Asialoglycoprotein receptor 1 is a novel PCSK9-independent ligand of liver LDLR cleaved by furin. J Biol Chem. 2021; 297(4):101177. PMC: 8479480. DOI: 10.1016/j.jbc.2021.101177. View

Nomura A, Sato T, Tada H, Kannon T, Hosomichi K, Tsujiguchi H . Polygenic risk scores for low-density lipoprotein cholesterol and familial hypercholesterolemia. J Hum Genet. 2021; 66(11):1079-1087. DOI: 10.1038/s10038-021-00929-7. View

Kenny D, Plichta D, Shungin D, Koppel N, Hall A, Fu B . Cholesterol Metabolism by Uncultured Human Gut Bacteria Influences Host Cholesterol Level. Cell Host Microbe. 2020; 28(2):245-257.e6. PMC: 7435688. DOI: 10.1016/j.chom.2020.05.013. View

Jang H, Lee S, Yang J, Lee H, Shin D, Lee H . Cyclase-associated protein 1 is a binding partner of proprotein convertase subtilisin/kexin type-9 and is required for the degradation of low-density lipoprotein receptors by proprotein convertase subtilisin/kexin type-9. Eur Heart J. 2019; 41(2):239-252. PMC: 6945527. DOI: 10.1093/eurheartj/ehz566. View

10.

Naj A . Genotype Imputation in Genome-Wide Association Studies. Curr Protoc Hum Genet. 2019; 102(1):e84. DOI: 10.1002/cphg.84. View

11.

Garcia C, Wilund K, Arca M, Zuliani G, Fellin R, Maioli M . Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science. 2001; 292(5520):1394-8. DOI: 10.1126/science.1060458. View

12.

Garcia-Rios A, Perez-Martinez P, Fuentes F, Mata P, Lopez-Miranda J, Alonso R . Genetic variations at ABCG5/G8 genes modulate plasma lipids concentrations in patients with familial hypercholesterolemia. Atherosclerosis. 2010; 210(2):486-92. PMC: 2905734. DOI: 10.1016/j.atherosclerosis.2010.01.010. View

13.

Shoulders C, Brett D, Bayliss J, Narcisi T, Jarmuz A, Grantham T . Abetalipoproteinemia is caused by defects of the gene encoding the 97 kDa subunit of a microsomal triglyceride transfer protein. Hum Mol Genet. 1993; 2(12):2109-16. DOI: 10.1093/hmg/2.12.2109. View

14.

Klimentidis Y, Arora A, Newell M, Zhou J, Ordovas J, Renquist B . Phenotypic and Genetic Characterization of Lower LDL Cholesterol and Increased Type 2 Diabetes Risk in the UK Biobank. Diabetes. 2020; 69(10):2194-2205. PMC: 7506834. DOI: 10.2337/db19-1134. View

15.

He B, Kang S, Chen Z, Liu X, Wang J, Li X . Hypercholesterolemia risk associated Abca6 does not regulate lipoprotein metabolism in mice or hamster. Biochim Biophys Acta Mol Cell Biol Lipids. 2021; 1866(11):159006. DOI: 10.1016/j.bbalip.2021.159006. View

16.

Lin Q, Yin R, Guo T, Wu J, Sun J, Shen S . Association of the ST3GAL4 rs11220462 polymorphism and serum lipid levels in the Mulao and Han populations. Lipids Health Dis. 2014; 13:123. PMC: 4237880. DOI: 10.1186/1476-511X-13-123. View

17.

Fouchier S, Dallinga-Thie G, Meijers J, Zelcer N, Kastelein J, Defesche J . Mutations in STAP1 are associated with autosomal dominant hypercholesterolemia. Circ Res. 2014; 115(6):552-5. DOI: 10.1161/CIRCRESAHA.115.304660. View

18.

Kotzka J, Knebel B, Janssen O, Schaefer J, Soufi M, Jacob S . Identification of a gene variant in the master regulator of lipid metabolism SREBP-1 in a family with a novel form of severe combined hypolipidemia. Atherosclerosis. 2011; 218(1):134-43. DOI: 10.1016/j.atherosclerosis.2011.05.008. View

19.

Durst R, Ibe U, Shpitzen S, Schurr D, Eliav O, Futema M . Molecular genetics of familial hypercholesterolemia in Israel-revisited. Atherosclerosis. 2017; 257:55-63. DOI: 10.1016/j.atherosclerosis.2016.12.021. View

20.

Lee J, Kang H, Park H, Moon Y, Kang Y, Oh B . PPARα-dependent Insig2a overexpression inhibits SREBP-1c processing during fasting. Sci Rep. 2017; 7(1):9958. PMC: 5577246. DOI: 10.1038/s41598-017-10523-7. View